Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

PILA PHARMA

1.18 SEK

Less than 1K followers

PILA

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Valuation
Income statement

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for PILA PHARMA

EV/S

Median 2021-2025

P/B

Median 2021-2025

 
2019202020212022202320242025
Share price (SEK)--5.922.761.433.342.06
Shares18.518.518.520.626.730.442.1
Market cap--109.557.038.1101.786.7
Enterprise value--81.349.7--70.8
EV/S--113.026.5--62.6
EV/EBITDA--neg.neg.--neg.
EV/EBIT--neg.neg.--neg.
P/E--neg.neg.neg.neg.neg.
P/B--3.615.985.7219.345.87
P/S--152.330.326.1130.476.7
Dividend yield--0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio93.9 %63.7 %95.2 %87.5 %78.7 %84.6 %91.1 %
Gearing ratio-14.6 %-----
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.